Loading...
Recurrence of proteinuria after cessation of tocilizumab in patients with AA amyloidosis secondary to FMF
There is no established treatment protocol for amyloid-A (AA) amyloidosis secondary to Familial Mediterranean Fever (FMF). Recently, we reported the efficacy of tocilizumab in 11 amyloidosis cases associated with FMF. In 2 patients of 11, we discontinued the tocilizumab administeration owing to the...
Na minha lista:
| Udgivet i: | Eur J Rheumatol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Medical Research and Education Association
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6267750/ https://ncbi.nlm.nih.gov/pubmed/30071938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2018.17183 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|